Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(10)
PROCEDURE(6)
DRUG(6)
DEVICE(1)
Positron Emission Tomography (PET)
3 trials
phase_1phase_1_2phase_2
thomas-hope, university-of-california-san-francisco
Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)
2 trials
early_phase_1phase_1
thomas-hope
F-18 Fluoroethyltyrosine (FET)
1 trial
phase_2
thomas-hope
Technetium Tc 99M Medronate
1 trial
phase_2
university-of-california-san-francisco
General Electric (GE) SIGNA PET/MR
1 trial
not_applicable
university-of-california-san-francisco
Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)
1 trial
not_applicable
university-of-california-san-francisco
68Ga-FAP-2286
1 trial
phase_1
thomas-hope
177 Lutetium Prostate-Specific Membrane Antigen 617
1 trial
phase_1
thomas-hope

+12 more interventions

20 unique interventions4 categories

Analytics

Trial Phases

Phase 13
Phase 23

Trial Status

Completed2
Recruiting1
Terminated1
Other3

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT07054346Phase 1Recruiting
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
High-risk Prostate CancerLocalized Prostate CarcinomaProstate Cancer+2 more
PrincipalinvestigatorStart date: 2025-07-08
NCT06630845Not ApplicableActive Not Recruiting
Comparison of Whole Body DWI to FDG PET
Metastatic Cancer
PrincipalinvestigatorStart date: 2025-02-06
NCT05924672Phase 2Active Not Recruiting
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
PrincipalinvestigatorStart date: 2024-08-30
NCT05180162Phase 1Completed
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
Liver FibrosisMyocardial FibrosisPulmonary Fibrosis
PrincipalinvestigatorStart date: 2021-12-09
NCT04044937Phase 2Completed
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
Intracranial NeoplasmLow Grade GliomaRecurrent Glioblastoma+2 more
PrincipalinvestigatorStart date: 2018-10-29
NCT02177773Phase 1/2Terminated
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
Carcinoid TumorsNeuroblastomaNeuroendocrine Tumor+1 more
PrincipalinvestigatorStart date: 2014-06-23
NCT07052760Early Phase 1Withdrawn
Imaging of Solid Tumors Using DLL3 SPECT
Castration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)Neuroendocrine (NE) Tumors+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerCastration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

Worked with same sponsors:

NovartisUniversity of California, San Francisco
Similarity Score4%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Prostate CancerCastration Resistant Prostate CancerMetastatic Cancer
Similarity Score4%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

NeuroblastomaNeuroendocrine TumorsPulmonary Fibrosis
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerNeuroendocrine Tumors
Similarity Score2%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Prostate CancerPulmonary Fibrosis
Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

NeuroblastomaProstate Cancer
Similarity Score2%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Prostate CancerMetastatic Cancer
Similarity Score2%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Fibrosis, LiverProstate Cancer

Worked with same sponsors:

Novartis
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neuroblastoma
Similarity Score1%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Fibrosis, Liver
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT07054346Phase 1PrincipalInvestigator

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

High-risk Prostate CancerLocalized Prostate CarcinomaProstate Cancer+2 more
Recruiting
NCT06630845Not ApplicablePrincipalInvestigator

Comparison of Whole Body DWI to FDG PET

Metastatic Cancer
Active Not Recruiting
NCT05924672Phase 2PrincipalInvestigator

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
Active Not Recruiting
NCT05180162Phase 1PrincipalInvestigator

Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Liver FibrosisMyocardial FibrosisPulmonary Fibrosis
Completed
NCT04044937Phase 2PrincipalInvestigator

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Intracranial NeoplasmLow Grade GliomaRecurrent Glioblastoma+2 more
Completed
NCT02177773Phase 1/2PrincipalInvestigator

GA-68 DOTA-TOC of Somatostatin Positive Malignancies

Carcinoid TumorsNeuroblastomaNeuroendocrine Tumor+1 more
Terminated
NCT07052760Early Phase 1PrincipalInvestigator

Imaging of Solid Tumors Using DLL3 SPECT

Castration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)Neuroendocrine (NE) Tumors+1 more
Withdrawn

All 7 trials loaded